TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NRIX

Nurix Therapeutics Inc

Healthcare · Biotechnology

25.40$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Nurix Therapeutics Inc (NRIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 688 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NRIX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
45 44 396 477 417 356 669 688
41 39 298 311 318 296 619 607
26 35 119 81 64 55 110 247
39 38 281 296 309 288 610 593
11 6.2 1.1 0.8 1.5
0.0 -1.1
4.4 3.9 6.7 25 17
34 54 106 134 113 155 142 149
33 16 45 66 71 87 96 86
2.8 4.6 7.6 3.8 5.5 7.5 8.0 2.8
1.3 1.6 3.4 6.7 5.1 6.4 11 11
-37 -58 290 342 304 200 527 539
-39 -60 -104 -221 -401 -545 -739 -1,003
16 39 16 43 49 54 67 87

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?